Inari Medical Inc (NARI)
Debt-to-capital ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 464,910 | 452,142 | 435,645 | 426,736 | 417,002 | 415,099 | 413,778 | 418,812 | 239,209 | 234,370 | 221,821 | 213,611 | 200,254 | 191,484 | 183,870 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $464,910K)
= 0.00
The debt-to-capital ratio of Inari Medical Inc has consistently been 0.00 across all quarters from Q1 2022 to Q4 2023. This indicates that the company has not used any debt to finance its operations or investments during this period. A debt-to-capital ratio of 0.00 suggests that the company relies entirely on equity financing, which may indicate a strong financial position and low financial risk. However, it is important to note that relying solely on equity funding may potentially limit the company's growth opportunities compared to leveraging debt for strategic investments.
Peer comparison
Dec 31, 2023